[1]
Anwar Khalil Ismael and Hazima Mossa Alabassi 2023. PD-1 and NFATc1 as promising immunotherapy for SLE patients. Journal of Population Therapeutics and Clinical Pharmacology. 30, 5 (Mar. 2023), 260–266. DOI:https://doi.org/10.47750/jptcp.2023.30.05.025.